Sensei Biotherapeutics Inc. (NASDAQ: SNSE) Stock Information | RedChip

Sensei Biotherapeutics Inc. (NASDAQ: SNSE) Listen to this Section


$0.63
+0.0250 ( +4.11% ) 15.0K

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

Market Data


Open


$0.63

Previous close


$0.61

Volume


15.0K

Market cap


$15.47M

Day range


$0.58 - $0.63

52 week range


$0.51 - $1.94

Insider Ownership Transactions

Total Amount Purchased: -178,470.00 | $ -113,149.98

Date Type Amount Purchased Purchaser
2024-02-16 Sale -3627.00 Colgan Erin
2023-11-02 Sale -125000.00 Krebs Stephanie
2023-09-13 Buy 500.00 Celebi John
2023-09-11 Sale -9383.00 Gallagher Patrick Stephen
2023-09-11 Sale -9525.00 van der Horst Edward
2023-09-11 Sale -20492.00 Celebi John
2023-09-11 Sale -10943.00 Colgan Erin

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
8-k 8K-related 65 Jun 03, 2024
8-k 8K-related 15 May 23, 2024
3 Insider transactions 2 May 16, 2024
8-k 8K-related 15 May 09, 2024
10-q Quarterly Reports 74 May 09, 2024
def Proxies and info statements 4 Apr 29, 2024
ars Annual reports 1 Apr 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.